Washington: A chemically synthesised version of the drug `rapamycin`, earlier used as an immunosuppressive agent, could be highly effective in treating kidney diseases, scientists have claimed. Scientists at UC Santa Barbara along with a biotech firm based in Indiana found a signalling protein called mTOR was found to drive cyst growth in polycystic kidney disease. Rapamycin inhibited the growth of cysts, the study found.
MEMD: Gadkari, Uma Bharti join the campaign
PM Narendra Modi addresses DRDO scientists
Sonia Gandhi targets PM Modi yet again
PM Narendra Modi`s Parliamentary office to be inaugurated in Varanasi today